In the Campus

The workshop is designed to be a combination of theoretical and hands-on sessions, providing students the… Read More

A new study has uncovered a critical mechanism that drives the inflammatory bowel disease (IBD), shedding light on… Read More

A workshop to understand the concept and practice of research uptake which ensures research findings are… Read More

Top Stories

News

The Industrious Immunologist

News

Union Minister Dr. Jitendra Singh

News

New Immune Pathway in Dengue: A

News

World TB Day 2025

News

National Science Day 2025

News

SProtFP: a machine learning-based

News

NII at a glance

News

NII Distinguished Lecture

News

The Prof Vijayan School of

News

Identification of pan-serotype drug

News

A novel structure-based method to

News

Annual Report 2023-2024

News

Conversations

News

Status, stress and responses

News

Rethinking immune strategies: T cell

News

Open Day at NII

News

The 2nd HFSP Frontier Workshop:

News

India International Science Festival

News

India International Science Festival

News

Helical domain changes between human

News

Public lecture

News

Public lecture

News

India Unveils BioE3 Policy to

News

Annual General Meeting of BRIC

News

New drug candidates to overcome

News

Research Facility Visits

News

Science Setu: Bridging Research and

Latest News

Latest News

Development of a Monoclonal Antibody-Based

Researchers at the BRIC-National Institute of Immunology (NII), New Delhi, in their recent study, focus on the development of monoclonal antibodies (mAbs) as a novel and potent alternative to traditional vaccines. 

Science Setu

Science Setu

India International Science Festival 2024

The 10th India International Science Festival took place at IIT-Guwahati, where NII showcased its groundbreaking research outcomes.

India International Science Festival 2024

The 10th India International Science Festival took place at IIT-Guwahati, where NII showcased its groundbreaking research outcomes.

Research Facility Visits

In the lab

In the lab

Development of a Monoclonal Antibody-Based

Researchers at the BRIC-National Institute of Immunology (NII), New Delhi, in their recent study, focus on the development of monoclonal antibodies (mAbs) as a novel and potent alternative to traditional vaccines. 

Fine-Tuning Cancer Immunotherapy with Artificial

In a significant step toward improving immune-based therapies for cancer, a team of researchers from the National Institute of Immunology, India, has taken a leap forward in enhancing the body’s natural defenses using precision-engineered nanoparticles.

 

Trending Videos

Reports / Media

NII at a glance

Annual Report 2023-2024

Feature

The Industrious Immunologist

Conversations

Sticky Menu
COLOR SKINS
COLOR SCHEMES